HC Wainwright Has Positive Estimate for TRDA Q2 Earnings
Entrada Therapeutics, Inc. (NASDAQ:TRDA – Free Report) – Stock analysts at HC Wainwright upped their Q2 2025 earnings per share (EPS) estimates for Entrada Therapeutics in a report released on Tuesday, May 20th. HC Wainwright analyst R. Selvaraju now expects that the company will post earnings of ($0.98) per share for the quarter, up from […]
Entrada Therapeutics, Inc. (NASDAQ:TRDA – Free Report) – Stock analysts at HC Wainwright upped their Q2 2025 earnings per share (EPS) estimates for Entrada Therapeutics in a report released on Tuesday, May 20th. HC Wainwright analyst R. Selvaraju now expects that the company will post earnings of ($0.98) per share for the quarter, up from […]
